Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells

Aim. The human GSTP1 is a major enzyme of phase II detoxification in the most cell types. Aberrant expression of GSTP1 is associated with carcinogenesis and development of multidrug resistance. The GSTP1 gene expression is regulated at multiple levels including transcriptional, post-transcriptional...

Full description

Saved in:
Bibliographic Details
Date:2009
Main Authors: Slonchak, A.М., Cwieduk, A., Rzerzowska-Wolny, J., Obolenskaya, M.Yu.
Format: Article
Language:English
Published: Інститут молекулярної біології і генетики НАН України 2009
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/5659
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells / А.М. Slonchak, А. Cwieduk, J. Rzerzowska-Wolny, M.Yu. Obolenskaya // Біополімери і клітина. — 2009. — Т. 25, № 3. — С. 210–217. — Бібліогр.: 22 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1859643292722921472
author Slonchak, A.М.
Cwieduk, A.
Rzerzowska-Wolny, J.
Obolenskaya, M.Yu.
author_facet Slonchak, A.М.
Cwieduk, A.
Rzerzowska-Wolny, J.
Obolenskaya, M.Yu.
citation_txt Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells / А.М. Slonchak, А. Cwieduk, J. Rzerzowska-Wolny, M.Yu. Obolenskaya // Біополімери і клітина. — 2009. — Т. 25, № 3. — С. 210–217. — Бібліогр.: 22 назв. — англ.
collection DSpace DC
description Aim. The human GSTP1 is a major enzyme of phase II detoxification in the most cell types. Aberrant expression of GSTP1 is associated with carcinogenesis and development of multidrug resistance. The GSTP1 gene expression is regulated at multiple levels including transcriptional, post-transcriptional and post-translational. We concentrated our attention on the transcriptional level of regulation. Methods. Transient transfection of Me45 melanoma cells with constructs containing the luciferase gene under the control of complete and truncated GSTP1 promoter was utilized to identify a role of different promoter regions in regulation of the gene transcription in Me45 cells. To identify the transcription factors, interacting with the GSTP1 promoter sites, the competitive EMSA and super shift assay were applied. Results. GSTP1 transcription in Me45 cells is positively regulated by binding NF-kB to the cognate site and ERb in complex with unknown protein to the ARE site; the complex of ERb with c-Fos negatively regulates the gene expression via CRE site. The interaction of c-Fos/ERb with GSTP1 CRE site and indirect interaction of ERb with GSTP1 ARE were identified. Conclusions. The positive regulation of the human GSTP1 gene in Me45 melanoma cells is exerted via NF-kB and ARE sites and the negative one via CRE site of the promoter. ERb is indirectly involved in the regulation of GSTP1 transcription. It is bound via c-Fos with CRE site and via unknown protein with ARE site.
first_indexed 2025-12-07T13:24:17Z
format Article
fulltext ÃÅÍÎ̲ÊÀ, ÒÐÀÍÑÊÐÈÏÒÎ̲ÊÀ ² ÏÐÎÒÅÎ̲ÊÀ Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells A. M. Slonchak, A. Cwieduk1, J. Rzerzowska-Wolny1, M. Yu. Obolenskaya Institute of Molecular Biology and Genetics NAS of Ukraine 150, Zabolotnogo str., Kyiv Ukraine, 03680 1M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology in Gliwice Wybrzezhe Armiji Krajowej 15, 44-101, Gliwice, Poland elephass@gmail.com Aim. The human GSTP1 is a major enzyme of phase II detoxification in the most cell types. Aberrant expression of GSTP1 is associated with carcinogenesis and development of multidrug resistance. The GSTP1 gene expression is regulated at multiple levels including transcriptional, post-transcriptional and post-translational. We concentrated our attention on the transcriptional level of regulation. Methods. Transient transfection of Me45 melanoma cells with constructs containing the luciferase gene under the control of complete and truncated GSTP1 promoter was utilized to identify a role of different promoter regions in regulation of the gene transcription in Me45 cells. To identify the transcription factors, interacting with the GSTP1 promoter sites, the competitive EMSA and super shift assay were applied. Results. GSTP1 transcription in Me45 cells is positively regulated by binding NF-kB to the cognate site and ERb in complex with unknown protein to the ARE site; the complex of ERb with c-Fos negatively regulates the gene expression via CRE site. The interaction of c-Fos/ERb with GSTP1 CRE site and indirect interaction of ERb with GSTP1 ARE were identified. Conclusions. The positive regulation of the human GSTP1 gene in Me45 melanoma cells is exerted via NF-kB and ARE sites and the negative one via CRE site of the promoter. ERb is indirectly involved in the regulation of GSTP1 transcription. It is bound via c-Fos with CRE site and via unknown protein with ARE site. Keywords: glutathione S-transferase, promoter, transcription factors, NF-kB, estrogen receptor, melanoma, transcription regulation. Introduction. Glutathione S-transferases comprise a multigene superfamily of enzymes that catalyze the conjugation of electrophilic toxic compounds with glutathione, playing a key role in phase II of detoxification [1]. The human GSTP1 isoform is a major GST isoenzyme in most cell types, except hepa- tocytes [2]. Besides its typical role in detoxification it possesses other functions, including a ligandin function [3], modulation of signaling pathways [4], conjugation and transport of steroid hormones [5], and participates in dinitrosyl-diglutathionyl-iron complex storage and metabolism [6]. Aberrant expression of GSTP1 is associated with carcinogenesis and develop- ment of multidrug resistance (MDR). The regulation of the GSTP1 gene expression is in the focus of researchers and clinicians interests because the stimulation of GSTP1 expression is expected to be used as a preventive approach against cancer while its down-regulation is in need to counteract the develop- ment of MDR. The GSTP1 gene expression is regulated at multiple levels including transcriptional, post-trans- criptional and post-translational [7]. We concentrate 210 ISSN 0233-7657. Biopolymers and Cell. 2009. Vol. 25. N 3 Ó Institute of Molecular Biology and Genetics NAS of Ukraine, 2009 our attention on the transcriptional level of regulation. Despite the vast literature devoted to GSTP1 enzyme the functional characteristics of responsive elements in gene promoter and tissue-specific peculiarities of their regulation are poorly understood. Moreover the pre- vious investigations of molecular mechanisms involved in the GSTP1 regulation were focused mainly on breast cancer, leukemia and prostate cancer cells. In present research we performed a functional analysis of GSTP1 promoter in human melanoma cells Me45. We utilized truncated promoter constructions to compare the functional role of different cis-acting promoter ele- ments and identified transcription factors binding the responsive elements by competitive EMSA (electro- phoretic mobility shift assay) and supershift assay. Matherials and methods. Cell culture. Human melanona cell line Me45 was obtained from Polish Cell Bank and propagated in DMEM/F12 medium («Sig- ma», USA) supplemented with 588 mg/ml L-glutamine, 0.16 % NaHCO3, 10 % heat inactivated fetal calf serum («Gibco», USA) and 100 mg/ml gentamicine. Cells were grown at 37 °C in an atmosphere of 95 % air and 5 % CO2. Promoter deletion constructs. Fragments of GSTP1 gene promoter were prepared by PCR. The oligonuc- leotide 5'-ACTCACTGGTGGCGAAGACT-3' (positi- on +15 to +35) was used as the downstream primer for all constructions. Each of the following oligonucleoti- des was used as upstream primers to amplify promoter fragments: 5'-CATAAACACCA- ACCTCTTCCCC-3' (position –1379 to –1357) for pGSTP1415, 5'-ATAGC- CTAAGGCACAGCCAC-3' (position –1162 to –1142) for pGSTP1197, 5'-TTTCCTTTCCTCTAAGCGGC-3' (position –405 to –385) for pGSTP440, 5'-AGTCCGC- G GGACCCTCCAGA-3' (position –105 to –85) for pGSTP140 and 5'-AGAGCGGCCGGCGCCGTGAC- 3' (position –85 to –64) for pGSTP120. The amplified products were subcloned into pCR®2.1-TOPO® vector («Invitrogen», USA). The recombinant plasmids were sequenced and the orientation of inserts was deter- mined. Plasmids with directly oriented inserts were submitted to digestion with KpnI and XhoI. Excised in- serts were religated into pGL3-basic (plasmid with GloTM Lu- ciferase 3 basic) plasmid («Promega», USA). Resulted constructs were named pGSTPX, were X cor- responds to the length of the inserted promoter frag- ment and GSTP is the gene name. Sequences of relevant regions of the final constructs were confirmed by sequ- encing in both directions in OIigo.pl DNA IBB PAN Service (Poland). Transient transfection assay. Me45 cells were grown in 24-well plates to 60 % confluence and trans- fected with 500 ng of pGSTP together with 25 ng of pRL-TK (plasmid with Renilla Luciferase and Thómi- dine kinase Promoter) plasmid («Promega», USA) per well using LipofectamineTM LTX and PLUSTM reagents («Invitrogen», USA). After 20 h the firefly and renilla luciferase activities were assessed using Dual Lucife- rase® Reporter Assay System («Promega», USA). Electrophoretic mobility shift assay. Nuclear extracts from Me45 cells were prepared by modified method of Dignam et al. [8]. The following oligo- nucleotides and their complementary sequences were used as probes in EMSA experiment: ARE (Anti- oxidant Response Element of human GSTP1 promo- ter) 5'-CGCCGTGACTCAGCACTGGG-3', NF-kB- like (Nuclear Factor kB-like site of human GSTP1 pro- moter) 5'-TCCGCGGGACCCTCCAGAAG-3', NF-kB (Nuclear Factor kB site of human GSTP1 promoter) 5'-CTTAGGGAATTTCCCCCCGC-3', CRE (Cyclic AMP Response Element site of human GSTP1 promo- ter) 5'-GAGACTACGTCATAAAATAA-3', GATA (GATA-1 binding site of human GSTP1 promoter) 5'-GAGATCAATATCTAGAAATAA-3'. Probes (10 pmoles) were labeled with 20 pmoles [g-32P]-ATP 6000 Ci/mmole («Hartmann Analytic», Deutschland) by polynucleotide kinase («Roche», Switzerland). Unincorporated nucleotides were removed by gel-filtration through Bio-gel® P-30 («Bio-Rad», USA). Electrophoretic mobility shift assay was performed using Electropforetic mobility shift assay kit («Promega»). Consensus oligonucleotides for AP-1 (Activator Protein 1), NF-kB (Nuclear Factor kB), CREB (Cyclic AMP Response Element Binding protein), GATA, ER (Estrogen Receptor) and RAR (Retinoic Acid Receptor), antibodies against human c-Jun, c-Fos, MafF/G/K, ERb , Nrf3 (Nuclear erythroid 2 p45 related factor 3), NF-kB p50, NF-kB p65 and normal rabbit IgG were from «Santa Cruz Bio- technology» (USA). Results and discussion. Functional analysis of the GSTP1 promoter regions in Me45 cells. The structure 211 CROSSTALK BETWEEN TRANSCRIPTION FACTORS IN REGULATION OF THE HUMAN GSTP1 GENE EXPRESSION IN Me45 CELLS of GSTP1 promoter is summarized in fig. 1. To identify the role of GSTP1 promoter regions in regulation of GSTP1 transcription in Me45 cells we utilized transient transfection assay with reporter constructs containing complete or truncated GSTP1 promoter fused to the firefly luciferase gene. For this purpose we designed the reporter constructs each lacking the DNA fragment with one transcription factor binding site (fig. 2). The diagram in fig. 2 represents relative firefly luciferase activities in lysates of Me45 cells transfected with re- porter constructs. Each bar in the graph represents the average of 3 independent experiments with triplications in each. Transfection of the largest vector (pGSTP1415) containing the GSTP1 promoter fragment from –1379 to +35 resulted in relatively high level of f-luc gene expression in Me45 cells. Deletion of the GSTP1- flanking region between –1379 and –1162, containing GATA-binding site, did not influence significantly the expression of the reporter gene. Deletion of the region from –1162 to –405, which contains CRE and ATA- AA-repeat, resulted in increase of f-luc expression approximately 1.8-fold in comparison with previous construct. Further deletion of the region from –405 to –105, containing NF-kB site, reduced the reporter gene expression 1.6-fold. Deletion of the region from –105 to –85, known as an NF-kB-like element, resulted in 1.5-fold increase of f-luc expression. Thereby, the results of the transient transfection experiments suggest the presence of the negative regulatory elements located in the regions from –1162 to –405 and from –105 to –85. Also it provided the evidence for the presence of the strong positive regulatory element located from –405 to –105. The 212 SLONCHAK A. M. ET AL. Fig. 1. Structure of the human GSTP1 gene 5'-regulatory region and potential transcription factors interacting with it [9–13]: «+» – positive regulation; «–» – negative regulation; g – general transcription factors Fig. 2. Schematic representation of the reporter constructs and their activities in transfected Me45 cells. Relative luciferase activity was calculated as a ratio of firefly to renilla luciferase light emission. Cells cotransfected with pGL3-basic and pRL-TK vectors were as a negative control similar role of promoter sequences in the regulation of GSTP1 gene transcription was identified by Jhaveri and Morrow [14] for breast cancer cells. The study of ARE, NF-kB-like, NF-kB, CRE and GATA binding sites interactions with nuclear proteins from Me45 cells. For identification of the transcription factors interacting with the GSTP1 promoter the electrophoretic mobility shift assay (EMSA) was applied. The ability of 20 bp promoter fragments, containing ARE, NF- kB-like, NF-kB, CRE and GATA sites to bind nuclear proteins from Me45 cells was examined in this experiment. Fig. 3 shows that all oligonucleotides form complexes with nuclear proteins. Specificity of the protein binding was as- sessed in a competition experiment, in which nuclear proteins were preincubated in 50- and 100-fold molar excess of unlabeled probe. In this experiment we determined, that ARE, NF-kB and CRE sites specifically bind nuclear proteins while NF-kB-like and GATA sites do not. One band observed in all elrctrophoregrams was non-specific because it was not eliminated in competitive experiments (fig. 3, A, B, C). Surprisingly, we did not find any proteins in- teracting with NF-kB-like element which was iden- tified as a negative regulator of GSTP1 transcription in the transient transfection experiment. We suppose that the «negative» role of the NF- B-like element in GSTP1 transcription may be connected with the presence of palindrome GGGACCCtc in the region that may hinder an enchanceosome formation. The region spanning nucleotides from –85 to +35 which is shown to be able to support the transcription of the reporter gene in Me45 cell at the level even higher than the full-length promoter is known to be a minimal promoter essential for the GSTP1 gene expression. This minimal promoter region contains ARE site which interacts with different transcription factors – AP-1 [15], Nrf2 [16], ERb [17] and RARa [18], depending on cell type. To identify the transcription factors acting on this site in Me45 cells we performed competitive EMSA with consensus oligos for AP-1, Maf (the DNA-binding component of Nrf2), ERb and RARa and supershift assay with antibodies for these trans- cription factors. Consistent with results shown in fig. 4, A, a 50- and 100-fold molar excess of unlabeled con- sensus oligonucleotides for AP-1, Maf, estrogen receptor beta (ERb) and retinoic acid receptor (RAR) were not able to compete for the nuclear proteins binding to the ARE site. It means that AP-1, Maf, ERb and RARa do not interact with ARE site through their DNA-binding domains. To clarify these results the supershift experiment with polyclonal antibodies to c-Jun (cross-reactive to JunB and JunD), c-Fos (cross-reactive to FosB, Fra1 and Fra2), MafF/G/K, ER b and Nrf3 (the placenta-specific homolog of Nrf2) was performed. As indicated in fig. 4, A, neither transcription factors Jun, Fos nor Maf and Nrf3 prevent the formation of specific complex of ARE site with a nuclear protein. Only ERb antibody prevents the whole complex formation resulting in appearance of a new complex with higher electrophoretic mobility. This result clearly indicates that in Me45 nuclear extracts ER b binds to the GSTP1 ARE site through another yet unknown protein and DNA-binding domain of ERb is not involved in these interactions. The region of GSTP1 promoter from –405 to –105 contains NF-kB site and positively regulates the reporter gene transcription in Me45 cells. This site binds NF-kB in K562 leukemia cells and mediates the gene induction by TNFa [11]. The results of the GSTP1 promoter NF-kB site binding assay are 213 CROSSTALK BETWEEN TRANSCRIPTION FACTORS IN REGULATION OF THE HUMAN GSTP1 GENE EXPRESSION IN Me45 CELLS Fig. 3. In vitro binding of Me45 nuclear proteins to GSTP1 promoter sites: A – electrophoretic mobility shift assay, demonstrating the ability of Me45 nuclear proteins to form complexes with ARE, NF- kB, NF-kB-like, CRE and GATA sites; B – results of competitive EMSA demonstrating, that protein binding to NF-kB-like site is nonspecific; C – results of competitive EMSA demonstrating, that protein binding to GATA site is nonspecific; S – specific complex; NS – nonspecific complex summarized in fig. 4, B. Two specific bands were observed in the reaction of genuine NF-kB site containing oligo with nuclear extract. The unlabeled NF-kB consensus was able to efficiently compete for the nuclear proteins from both specific complexes leading to suggestion that NF- kB binds to GSTP1 NF-kB site in this cell line. To clarify the matter, nuclear extract was incubated with polyclonal antibodies to p50 and p65 subunits of NF- kB before the probe was added to the EMSA reaction. In the supershift assay of NF-kB site two new bands were observed after the incubation with p50 antibody – one originated from the lower and one from the upper complex, providing the evidence that both complexes contain p50. The upper complex of nuclear proteins and NF-kB site contains the p50/p65 heterodimer, while the lower complex observed in binding reaction is the p50/p50. These data together with the results of transient transfection assay strongly suggest that NF- kB interacts with the human GSTP1 NF-kB site and up-regulates gene transcription in Me45 cells. The negative regulatory element –1162 … –404 contains a CRE site and ATAAA-repeated sequence. It was previously reported that CRE site of GSTP1 mediates gene response to cAMP by interacting with CREB in Calu-6 lung cancer cells [19]. Competitive EMSA was also conducted to determine which protein is a part of the DNA-protein complex formed by CRE 214 SLONCHAK A. M. ET AL. Fig. 4. Analysis of the complexes formed by ARE, NF- B and CRE sites from the human GSTP1 promoter: A – ARE-protein complex formation was inhibited by unlabeled ARE site (cold probe) and by ERb antibody; B – NF-kB site forms two complexes with the nuclear proteins from Me45 cells; both complexes were disrupted by the cold probe and NF-kB consensus and supershifted by p50 antibody; p65 antibody disrupted only the upper complex; C – CRE site from the human GSTP1 promoter interacts with Me45 nuclear proteins and the complex formation can be inhibited by the cold probe; AP-1, but not CRE consensus compete with the CRE for the nuclear proteins and antibodies to Fos and ERb supershift the complexes site in Me45. Regarding the ability of CRE sites in different genes to interact with CREB [19] and AP-1[20] proteins, consensus oligonucleotides for both transcription factors were utilized in the competitive EMSA. A representative autoradiograph in fig. 4, C, shows, that CREB consensus oligonucleotide could not compete with GSTP1 promoter CRE for protein binding, however genuine oligonucleotide CRE and AP-1 consensus competed successfully. This suggests that CRE site forms the complex with AP-1 in Me45 cells. The supershift experiment with antibodies against the transcription factors known to interact directly or indirectly with CREs of other genes was performed to verify the results. Antibodies to c-Jun (cross-reactive to JunB and JunD), c-Fos (cross-reactive to FosB, Fra1 and Fra2), MafF/G/K, ERb and Nrf3 were utilized in this assay. The supershifted bands were observed after the incubation of nuclear extracts with Fos and ERb antibodies. The supershift analysis indicates that ERb together with Fos protein interacts with the human GSTP1 CRE in Me45 cells and this interaction has a negative regulatory effect. The phenomenon that protein binding sites can be shared between different transcription factors is called a transcription factor crosstalk [20]. It can be realized by interaction of a «noncanonical» transcription factor directly with a DNA sequence which has a partial homology to the binding sites of this and another transcription factors [20] or by protein-protein inter- actions of «noncanonical» transcription factor with a «genuine» protein bound to its recognition site. In case of the human GSTP1 promoter both types of crosstalk are present – noncanonical c-Fos together with ERb crosstalks with CREB at CRE site and ERb together with an unknown protein crosstalks with AP-1 at ARE site. In both cases CREB and Fos/Jun has an opposite effect on gene transcription. In case of the GSTP1 promoter this negative effect is seems to be potentiated by ERb binding which is known to repress Fos-driven transcription [21]. In the present finding we identified ERb indirectly interacting with two promoter ele- ments – CRE and ARE sites. It evidences for the importance of this protein for the formation of the enchanceosome on GSTP1 promoter. The ER signaling mechanisms discussed until now provide an explanation for the regulation of genes lacking estrogen response element and requiring a second DNA-binding transcription factor to mediate ER association with the DNA. ERa and ERb have been shown to act in opposite ways at Fos/Jun-binding sites. In the presence of E2 ERa activates transcription via its AF-1 and AF-2 transactivating domains while ERb-E2 which lacks a functional AF-1inhibits the Fos/Jun- dependent transcription [22]. We suggest that ERb exerts the similar inhibitory effect at CRE site of GSTP1 promoter. The role of ERb associated with an unknown protein at ARE site is different and may activate transcription. The dual function of ERb in regulation of different promoter elements may be considered in context of enchanceosome formation. Conclusions. In the present research the transcriptional mechanisms controlling the basal level of GSTP1 expression in Me45 cells have been analyzed for the first time. The obtained data indicate that the GSTP1 transcription in this cell type is positively regulated by binding of NF-kB to –323 site and ERb in complex with unknown protein binding to the ARE site; the complex of ERb with c-Fos at CRE site nega- tively regulates the gene expression. The interaction of c-Fos/ERb with GSTP1 CRE site and indirect inter- action of ER with GSTP1 ARE site have been discovered. The regulation of GSTP1 transcription in Me45 melanoma cells has been examined in details also for the first time. Several transcription factors – NF-kB in p50/p50 homodimer and p50/p65 heterodimer, ERb and c-Fos regulate GSTP1 transcription in these cells. Positive regulation is exerted via NF-kB and ARE sites and negative via CRE site. ERb is indirectly involved in regulation of GSTP1 transcription. It is bound via c-Fos with CRE site and via unknown protein with ARE site. A. M. Ñëîí ÷àê, A. Êâå äóê, É. Æå øîâ ñêà-Âîëüíè, Ì. Þ. Îáî ëå íñüêà Ïå ðå ãî âî ðè ì³æ òðàíñ êðèïö³éíè ìè ôàê òî ðà ìè ó ðå ãó ëÿö³¿ åêñïðåñ³¿ ãåíà Ð1 ãëó òàò³îí-S-òðàíñ ôå ðà çè ëþ äè íè ó êë³òè íàõ ìå ëà íî ìè Ìå45 Ðeçþìe Ìåòà.Ãëó òàò³îí-S-òðàíñ ôå ðà çà (GTà çà) ëþ äè íè º ãî ëîâ íèì ôåð ìåí òîì II ôàçè äå òîê ñè êàö³¿ ó á³ëüøîñò³ òèï³â êë³òèí. Çì³íà ð³âíÿ åêñïðåñ³¿ ¿¿ ãåíà ïî â’ÿ çàíà ç êàí öå ðî ãå íå çîì ³ ôîð - ìó âàí íÿì ÷èñ ëåí íî¿ ë³êà ðñüêî¿ ñò³éêîñò³. Åêñïðåñ³ÿ GTà çèÐ1 215 CROSSTALK BETWEEN TRANSCRIPTION FACTORS IN REGULATION OF THE HUMAN GSTP1 GENE EXPRESSION IN Me45 CELLS ðå ãó ëþºòüñÿ íà òðàíñ êðèïö³éíî ìó, ïî còòðà íñêðèïö³éíî ìó òà ïî ñòòðàí ñëÿö³éíî ìó ð³âíÿõ. Ó äàí³é ðî áîò³ ìè çî ñå ðå äè ëè ñÿ íà òðàíñ êðèïö³éí³é ðå ãó ëÿö³¿ ãåíà. Ìå òî äè. Òðàí ñôåêö³þ êë³òèí ìå ëà íî ìè Ìå45 êî íñòðóêö³ÿìè, ÿê³ ì³ñòÿòü ãåí ëþ öè - ôå ðà çè ï³ä êîí òðî ëåì ïî âíî ãî àáî âêî ðî ÷å íî ãî ïðî ìî òî ðà GTà çèÐ1, âè êî ðèñ òà íî äëÿ âñòà íîâ ëåí íÿ ðîë³ ð³çíèõ ä³ëÿ íîê ïðî ìî òî ðà â ðå ãó ëÿö³¿ òðàíñ êðèïö³¿ ãåíà GTà çè Ð1 ó êë³òè íàõ Ìå45. Ùîá âèç íà ÷è òè òðàíñ êðèïö³éí³ ôàê òî ðè, ÿê³ âçàº- ìîä³þòü ç ïðî ìî òî ðîì ãåíà GTà çèÐ1, âè ÿâ ëÿ ëè çì³íè åëåê òðî - ôî ðå òè÷ íî¿ ðóõ ëè âîñò³ ÄÍÊ-á³ëêî âèõ êîì ïëåêñ³â çà ïðè ñóò - íîñò³ àí òèò³ë ³ êîí êó ðåí òíèõ îë³ãî íóê ëå î òèä³â. Ðå çóëü òà òè. Òðà íñêðèïö³ÿ ãåíà GTà çèÐ1 ó êëè òè íàõ Me45 ïî çè òèâ íî ðå ãó - ëþºòüñÿ ÷å ðåç çâ’ÿ çó âàí íÿ NF-kB ³ç ñàé òîì –323 òà çà ðà õó íîê çâ’ÿ çó âàí íÿ ERb y êîì ïëåêñ³ ç íåâ³äî ìèì á³ëêîì – ç ARE-ñàé - òîì; êîì ïëåêñ ERb ç c-Fos íå ãà òèâ íî ðå ãó ëþº åêñïðåñ³þ ãåíà. Âñòà íîâ ëå íî òà êîæ ïðÿ ìó âçàºìîä³þ c-Fos/ERb ³ç ñàé òîì CRE ãåíà GTà çèÐ1 ³ íå ïðÿìy – ERb ³ç ñàé òîì ARE. Âèñ íîâ êè. Ïî çè òèâ íà ðå ãó ëÿö³ÿ ãåíà GTà çèÐ1 ëþ äè íè â êë³òè íàõ ìå ëà íî - ìè Me45 çä³éñíþºòüñÿ ÷å ðåç NF-kB ³ ARE-ñàé òè, à íå ãà òèâ íà – ÷å ðåç CRE-ñàéò ïðî ìî òî ðà. ERb îïî ñå ðåä êî âà íî áåðå ó÷àñòü ó ðå ãó ëÿö³¿ òðàíñ êðèïö³¿ GTà çèÐ1: ÷å ðåç c-Fos â³í çâ’ÿ çóºòüñÿ ç CRE-ñàé òîì ³ ÷å ðåç íåâ³äî ìèé á³ëîê – ç ARE-ñàé òîì. Êëþ ÷îâ³ ñëî âà: ãëó òàò³îí-S-òðàíñ ôå ðà çà, ïðî ìî òîð, òðàíñ êðèïö³éí³ ôàê òî ðè, NF-kB, åñ òðà ãå íî âèé ðå öåï òîð, ìå - ëà íî ìà, ðå ãó ëÿö³ÿ òðàíñ êðèïö³¿. A. M. Ñëîí ÷àê, A. Êâå äóê, É. Æå øîâ ñêà-Âîëü íû, Ì. Þ. Îáî ëåí ñêàÿ Ïå ðå ãî âî ðû ìåæ äó òðàíñ êðèï öè îí íû ìè ôàê òî ðà ìè â ðå ãó ëÿ öèè ýêñ ïðåñ ñèè ãåíà Ð1 ãëó òà òè îí-S-òðàíñ ôå ðà çû ÷å ëî âå êà â êëåò êàõ ìå ëà íî ìû Ìå45 Ðeçþìe Öåëü. Ãëó òà òè îí-S-òðàíñ ôå ðà çà (GTà çà) ÷å ëî âå êà ÿâ ëÿ åò ñÿ ãëàâ íûì ôåð ìåí òîì II ôàçû äå òîê ñè êà öèè â áîëü øè íñòâå òè - ïîâ êëå òîê. Èçìå íå íèå óðîâ íÿ ýêñ ïðåñ ñèè åå ãåíà ñâÿ çà íî ñ êàí - öå ðî ãå íå çîì è ôîð ìè ðî âà íè åì ìíî æåñ òâåí íîé ëå êà ðñòâåí- íîé óñòîé ÷è âîñ òè. Ýêñïðåñ ñèÿ GTà çûÐ1 ðå ãó ëè ðó åò ñÿ íà òðàíñ êðèï öè îí íîì, ïî còòðà íñêðèï öè îí íîì è ïî ñòòðàí ñëÿ - öè îí íîì óðîâ íÿõ.  äàí íîé ðà áî òå ìû ñî ñðå äî òî ÷è ëèñü íà òðàíñ êðèï öè îí íîé ðå ãó ëÿ öèè ãåíà. Ìå òî äû. Òðàí ñôåê öèÿ êëå - òîê ìå ëà íî ìû Ìå45 êî íñòðóê öè ÿ ìè, ñî äåð æà ùè ìè ãåí ëþ öè - ôå ðà çû ïîä êîí òðî ëåì ïî ëíî ãî èëè óêî ðî ÷åí íî ãî ïðî ìî òî ðà GTà çûÐ1, èñ ïîëü çî âà íà äëÿ âû ÿñ íå íèÿ ðîëè ðàç íûõ ó÷àñ òêîâ ïðî ìî òî ðà â ðå ãó ëÿ öèè òðàíñ êðèï öèè ãåíà GTà çû Ð1 â êëåò êàõ Ìå45. ×òî áû âû ÿ âèòü òðàíñ êðèï öè îí íûå ôàê òî ðû, âçà è ìî - äå éñòâó þ ùèå ñ ïðî ìî òî ðîì ãåíà GTà çûÐ1, îïðå äå ëÿ ëè èç ìå - íå íèÿ ýëåê òðî ôî ðå òè ÷åñ êîé ïîä âèæ íîñ òè ÄÍÊ-áåë êî âûõ êîì ïëåê ñîâ â ïðè ñó òñòâèè àí òè òåë è êîí êó ðåí òíûõ îëè ãî íóê - ëå î òè äîâ. Ðå çóëü òà òû. Òðà íñêðèï öèÿ ãåíà GTà çûÐ1 â êëåò êàõ Me45 ïî çè òèâ íî ðå ãó ëè ðó åò ñÿ ÷å ðåç ñâÿ çû âà íèå NF-kB ñ ñàé - òîì –323 è ÷å ðåç ñâÿ çû âà íèå ERb â êîì ïëåê ñå ñ íå èç âåñ íûì áåë - êîì – ñ ARE-ñàé òîì; êîì ïëåêñ ERb ñ c-Fos íå ãà òèâ íî ðå ãó ëè- ðóåò ýêñ ïðåñ ñèþ ãåíà. Óñòà íîâ ëå íî òàê æå ïðÿ ìîå âçà è ìî äåé- ñòâèå c-Fos/ERb ñ ñàé òîì CRE ãåíà GTà çûÐ1 è íå ïðÿ ìîå – ERb ñ ñàé òîì ARE. Âû âî äû. Ïî çè òèâ íàÿ ðå ãó ëÿ öèÿ ãåíà GTà çûÐ1 ÷å ëî âå êà â êëåò êàõ ìå ëà íî ìû Me45 îñó ùå ñòâëÿ åò ñÿ ÷å ðåç NF- kB è ARE-ñàé òû, à íå ãà òèâ íàÿ – ÷å ðåç CRE-ñàéò ïðî ìî òî ðà. ERb îïîñ ðå äî âàí íî ó÷àñ òâó åò â ðå ãó ëÿ öèè òðàíñ êðèï öèè GTà - çûÐ1: ÷å ðåç c-Fos îí ñâÿ çû âà åò ñÿ ñ CRE-ñàé òîì è ÷å ðåç íå èç - âåñ òíûé áå ëîê – ñ ARE-ñàé òîì. Êëþ ÷å âûå ñëî âà: ãëó òà òè îí-S-òðàíñ ôå ðà çà, ïðî ìî òîð, òðàíñ êðèï öè îí íûå ôàê òî ðû, NF-kB, ýñ òðà ãå íî âûé ðå öåï òîð, ìå ëà íî ìà, ðå ãó ëÿ öèÿ òðàíñ êðèï öèè. REFERENCES 1. Hayes J. D., Flanagan J. U., Jowsey I. R. Glutathione transferases // Annu. Rev. Pharmacol. Toxicol.–2005.–45.– P. 51–88. 2. Moscow J. A., Fairchild C. R., Madden M. J., Ransom D. T., Wieand H. S., O’Brien E. E., Poplack D. G., Cossman J., My- ers C. E., Cowan K. H. Expression of anionic glutathione- S-transferase and P-glycoprotein genes in human tissues and tumors // Cancer Res.–1989.–49, N 6.–P. 1422–1428. 3. Oakley A. J., Lo B. M., Nuccetelli M., Mazzetti A. P., Parker M. W. The ligandin (non-substrate) binding site of human Pi class glutathione transferase is located in the electrophile binding site (H-site) // J. Mol. Biol.–1999.–291, N 4.–P. 913– 926. 4. Zhao X., Fan Y., Shen J., Wu Y., Yin Z. Human glutathione S-transferase P1 suppresses MEKK1-mediated apoptosis by regulating MEKK1 kinase activity in HEK293 cells // Mol. Cells.–2006.–21, N 3.–P. 395–400. 5. Paakki P., Kirkinen P., Helin H., Pelkonen O., Raunio H., Pasanen M. Antepartum glucocorticoid therapy suppresses human placental xenobiotic and steroid metabolizing enzy- mes // Placenta.–2000.–21, N 2–3.–P. 241–246. 6. Turella P., Pedersen J. Z., Caccuri A. M., De M. F., Mastro- berardino P., Lo B. M., Federici G., Ricci G. Glutathione transferase superfamily behaves like storage proteins for dinitrosyl-diglutathionyl-iron complex in heterogeneous sys- tems // J. Biol. Chem.–2003.–278, N 43.–P. 42294–42299. 7. Moffat G. J., McLaren A. W., Wolf C. R. Transcriptional and post-transcriptional mechanisms can regulate cell-specific expression of the human Pi-class glutathione S-transferase gene // Biochem. J.–1997.–324, ðt 1.–P. 91–95. 8. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate trans- cription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei // Nucl. Acids. Res.–1983.– 11, N 5.–P. 1475–1489. 9. Cowell I. G., Dixon K. H., Pemble S. E., Ketterer B., Taylor J. B. The structure of the human glutathione S-transferase Pi gene // Biochem. J.–1988.–255, N 1.–P. 79–83. 10. Xia C. L., Cowell I. G., Dixon K. H., Pemble S. E., Ketterer B., Taylor J. B. Glutathione transferase pi its minimal promoter and downstream cis-acting element // Biochem. Biophys. Res. Communs.–1991.–176, N 1.–P. 233–240. 11. Morceau F., Duvoix A., Delhalle S., Schnekenburger M., Di- cato M., Diederich M. Regulation of glutathione S-transfå- rase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells // Biochem. Phar- macol.–2004.–67, N 7.–P. 1227–1238. 12. Schnekenburger M., Morceau F., Duvoix A., Delhalle S., Trentesaux C., Dicato M., Diederich M. Expression of glu- tathione S-transferase P1-1 in differentiating K562: role of GATA-1 // Biochem. Biophys. Res. Communs.–2003.–311, N 4.–P. 815–821. 13. Moffat G. J., McLaren A. W., Wolf C. R. Sp1-mediated transc- riptional activation of the human Pi class glutathione S-trans- ferase promoter // J. Biol. Chem.–1996.–271, N 2.–P. 1054– 1060. 216 SLONCHAK A. M. ET AL. 14. Jhaveri M. S., Morrow C. S. Contribution of proximal promo- ter elements to the regulation of basal and differential gluta- thione S-transferase P1 gene expression in human breast can- cer cells // Biochim. Biophys. Acta.–1998.–1396, N 2.– P. 179–190. 15. Duvoix A., Schmitz M., Schnekenburger M., Dicato M., Mor- ceau F., Galteau M. M., Diederich M. Transcriptional regula- tion of glutathione S-transferase P1-1 in human leukemia // Biofactors.–2003.–17, N 1–4.–P. 131–138. 16. Nishinaka T., Ichijo Y., Ito M., Kimura M., Katsuyama M., Iwata K., Miura T., Terada T., Yabe-Nishimura C. Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element // Toxicol. Lett.– 2007.–170, N 3.–P. 238–247. 17. Montano M. M., Deng H., Liu M., Sun X., Singal R. Trans- criptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications // Oncogene.– 2004.–23, N 14.–P. 2442–2453. 18. Xia C., Hu J., Ketterer B., Taylor J. B. The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status // Biochem. J.–1996.–313, ðt 1.– P. 155–161. 19. Lo H. W., li-Osman F. Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: a novel mechanism of cellular GSTP1 gene regulation // J. Cell. Biochem.–2002.–87, N 1.– P. 103–116. 20. Manna P. R., Stocco D. M. Crosstalk of CREB and Fos/Jun on a single cis-element: transcriptional repression of the steroi- dogenic acute regulatory protein gene // J. Mol. Endocrinol.– 2007.–39, N 4.–P. 261–277. 21. Gottlicher M., Heck S., Herrlich P. Transcriptional cross- talk, the second mode of steroid hormone receptor action // J. Mol. Med.–1998.–76, N 7.–P. 480–489. 22. Marino M., Galluzzo P., Ascenzi P. Estrogen signaling mul- tiple pathways to impact gene transcription // Curr. Geno- mics.–2006.–7, N 8.–P. 497–508. ÓÄÊ 577.152.28 Íàä³éøëà äî ðå äàêö³¿ 23.03.09 217 CROSSTALK BETWEEN TRANSCRIPTION FACTORS IN REGULATION OF THE HUMAN GSTP1 GENE EXPRESSION IN Me45 CELLS
id nasplib_isofts_kiev_ua-123456789-5659
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 0233-7657
language English
last_indexed 2025-12-07T13:24:17Z
publishDate 2009
publisher Інститут молекулярної біології і генетики НАН України
record_format dspace
spelling Slonchak, A.М.
Cwieduk, A.
Rzerzowska-Wolny, J.
Obolenskaya, M.Yu.
2010-02-01T16:22:53Z
2010-02-01T16:22:53Z
2009
Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells / А.М. Slonchak, А. Cwieduk, J. Rzerzowska-Wolny, M.Yu. Obolenskaya // Біополімери і клітина. — 2009. — Т. 25, № 3. — С. 210–217. — Бібліогр.: 22 назв. — англ.
0233-7657
https://nasplib.isofts.kiev.ua/handle/123456789/5659
577.152.28
Aim. The human GSTP1 is a major enzyme of phase II detoxification in the most cell types. Aberrant expression of GSTP1 is associated with carcinogenesis and development of multidrug resistance. The GSTP1 gene expression is regulated at multiple levels including transcriptional, post-transcriptional and post-translational. We concentrated our attention on the transcriptional level of regulation. Methods. Transient transfection of Me45 melanoma cells with constructs containing the luciferase gene under the control of complete and truncated GSTP1 promoter was utilized to identify a role of different promoter regions in regulation of the gene transcription in Me45 cells. To identify the transcription factors, interacting with the GSTP1 promoter sites, the competitive EMSA and super shift assay were applied. Results. GSTP1 transcription in Me45 cells is positively regulated by binding NF-kB to the cognate site and ERb in complex with unknown protein to the ARE site; the complex of ERb with c-Fos negatively regulates the gene expression via CRE site. The interaction of c-Fos/ERb with GSTP1 CRE site and indirect interaction of ERb with GSTP1 ARE were identified. Conclusions. The positive regulation of the human GSTP1 gene in Me45 melanoma cells is exerted via NF-kB and ARE sites and the negative one via CRE site of the promoter. ERb is indirectly involved in the regulation of GSTP1 transcription. It is bound via c-Fos with CRE site and via unknown protein with ARE site.
en
Інститут молекулярної біології і генетики НАН України
Геноміка, транскриптоміка і протеоміка
Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells
Переговори між транскрипційними факторами у регуляції експресії гена Р1 глутатіон-S-трансферази людини у клітинах меланоми Ме45
Переговоры между транскрипционными факторами в регуляции экспрессии гена Р1 глутатион-S-трансферазы человека в клетках меланомы Ме45
Article
published earlier
spellingShingle Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells
Slonchak, A.М.
Cwieduk, A.
Rzerzowska-Wolny, J.
Obolenskaya, M.Yu.
Геноміка, транскриптоміка і протеоміка
title Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells
title_alt Переговори між транскрипційними факторами у регуляції експресії гена Р1 глутатіон-S-трансферази людини у клітинах меланоми Ме45
Переговоры между транскрипционными факторами в регуляции экспрессии гена Р1 глутатион-S-трансферазы человека в клетках меланомы Ме45
title_full Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells
title_fullStr Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells
title_full_unstemmed Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells
title_short Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells
title_sort crosstalk between transcription factors in regulation of the human glutathione s-transferase p1 gene expression in me45 melanoma cells
topic Геноміка, транскриптоміка і протеоміка
topic_facet Геноміка, транскриптоміка і протеоміка
url https://nasplib.isofts.kiev.ua/handle/123456789/5659
work_keys_str_mv AT slonchakam crosstalkbetweentranscriptionfactorsinregulationofthehumanglutathionestransferasep1geneexpressioninme45melanomacells
AT cwieduka crosstalkbetweentranscriptionfactorsinregulationofthehumanglutathionestransferasep1geneexpressioninme45melanomacells
AT rzerzowskawolnyj crosstalkbetweentranscriptionfactorsinregulationofthehumanglutathionestransferasep1geneexpressioninme45melanomacells
AT obolenskayamyu crosstalkbetweentranscriptionfactorsinregulationofthehumanglutathionestransferasep1geneexpressioninme45melanomacells
AT slonchakam peregovorimížtranskripcíinimifaktoramiuregulâcííekspresíígenar1glutatíonstransferazilûdiniuklítinahmelanomime45
AT cwieduka peregovorimížtranskripcíinimifaktoramiuregulâcííekspresíígenar1glutatíonstransferazilûdiniuklítinahmelanomime45
AT rzerzowskawolnyj peregovorimížtranskripcíinimifaktoramiuregulâcííekspresíígenar1glutatíonstransferazilûdiniuklítinahmelanomime45
AT obolenskayamyu peregovorimížtranskripcíinimifaktoramiuregulâcííekspresíígenar1glutatíonstransferazilûdiniuklítinahmelanomime45
AT slonchakam peregovorymeždutranskripcionnymifaktoramivregulâciiékspressiigenar1glutationstransferazyčelovekavkletkahmelanomyme45
AT cwieduka peregovorymeždutranskripcionnymifaktoramivregulâciiékspressiigenar1glutationstransferazyčelovekavkletkahmelanomyme45
AT rzerzowskawolnyj peregovorymeždutranskripcionnymifaktoramivregulâciiékspressiigenar1glutationstransferazyčelovekavkletkahmelanomyme45
AT obolenskayamyu peregovorymeždutranskripcionnymifaktoramivregulâciiékspressiigenar1glutationstransferazyčelovekavkletkahmelanomyme45